目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Therapy
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Peripheral Neuropathy Treatment Market 2018 - 2022
Historic Market Size - Data Table on Global Peripheral Neuropathy Treatment Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Therapy segment analysis 2018 - 2022
Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Diabetic peripheral neuropathy - Market size and forecast 2023-2028
Chart on Diabetic peripheral neuropathy - Market size and forecast 2023-2028 ($ million)
Data Table on Diabetic peripheral neuropathy - Market size and forecast 2023-2028 ($ million)
Chart on Diabetic peripheral neuropathy - Year-over-year growth 2023-2028 (%)
Data Table on Diabetic peripheral neuropathy - Year-over-year growth 2023-2028 (%)
6.4 Chemotherapy induced peripheral neuropathy - Market size and forecast 2023-2028
Chart on Chemotherapy induced peripheral neuropathy - Market size and forecast 2023-2028 ($ million)
Data Table on Chemotherapy induced peripheral neuropathy - Market size and forecast 2023-2028 ($ million)
Chart on Chemotherapy induced peripheral neuropathy - Year-over-year growth 2023-2028 (%)
Data Table on Chemotherapy induced peripheral neuropathy - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Therapy
7.1 Market segments
Chart on Therapy - Market share 2023-2028 (%)
Data Table on Therapy - Market share 2023-2028 (%)
7.2 Comparison by Therapy
Chart on Comparison by Therapy
Data Table on Comparison by Therapy
7.3 Pharmacological therapies - Market size and forecast 2023-2028
Chart on Pharmacological therapies - Market size and forecast 2023-2028 ($ million)
Data Table on Pharmacological therapies - Market size and forecast 2023-2028 ($ million)
Chart on Pharmacological therapies - Year-over-year growth 2023-2028 (%)
Data Table on Pharmacological therapies - Year-over-year growth 2023-2028 (%)
7.4 Non pharmacological therapies - Market size and forecast 2023-2028
Chart on Non pharmacological therapies - Market size and forecast 2023-2028 ($ million)
Data Table on Non pharmacological therapies - Market size and forecast 2023-2028 ($ million)
Chart on Non pharmacological therapies - Year-over-year growth 2023-2028 (%)
Data Table on Non pharmacological therapies - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Therapy
Market opportunity by Therapy ($ million)
Data Table on Market opportunity by Therapy ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Apotex Inc.
Apotex Inc. - Overview
Apotex Inc. - Product / Service
Apotex Inc. - Key news
Apotex Inc. - Key offerings
12.4 ASSERTIO HOLDINGS INC.
ASSERTIO HOLDINGS INC. - Overview
ASSERTIO HOLDINGS INC. - Product / Service
ASSERTIO HOLDINGS INC. - Key offerings
12.5 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.6 Cadila Pharmaceuticals Ltd.
Cadila Pharmaceuticals Ltd. - Overview
Cadila Pharmaceuticals Ltd. - Product / Service
Cadila Pharmaceuticals Ltd. - Key offerings
12.7 Cipla Inc.
Cipla Inc. - Overview
Cipla Inc. - Business segments
Cipla Inc. - Key news
Cipla Inc. - Key offerings
Cipla Inc. - Segment focus
12.8 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product / Service
Daiichi Sankyo Co. Ltd. - Key news
Daiichi Sankyo Co. Ltd. - Key offerings
12.9 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
12.10 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.11 Endo International Plc
Endo International Plc - Overview
Endo International Plc - Business segments
Endo International Plc - Key news
Endo International Plc - Key offerings
Endo International Plc - Segment focus
12.12 Hikma Pharmaceuticals Plc
Hikma Pharmaceuticals Plc - Overview
Hikma Pharmaceuticals Plc - Business segments
Hikma Pharmaceuticals Plc - Key news
Hikma Pharmaceuticals Plc - Key offerings
Hikma Pharmaceuticals Plc - Segment focus
12.13 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.14 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Product / Service
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
12.15 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.16 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Peripheral Neuropathy Treatment Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Type - Market share 2023-2028 (%)
Exhibits33: Data Table on Type - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Type
Exhibits35: Data Table on Comparison by Type
Exhibits36: Chart on Diabetic peripheral neuropathy - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Diabetic peripheral neuropathy - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Diabetic peripheral neuropathy - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Diabetic peripheral neuropathy - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Chemotherapy induced peripheral neuropathy - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Chemotherapy induced peripheral neuropathy - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Chemotherapy induced peripheral neuropathy - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Chemotherapy induced peripheral neuropathy - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by Type ($ million)
Exhibits49: Data Table on Market opportunity by Type ($ million)
Exhibits50: Chart on Therapy - Market share 2023-2028 (%)
Exhibits51: Data Table on Therapy - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Therapy
Exhibits53: Data Table on Comparison by Therapy
Exhibits54: Chart on Pharmacological therapies - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Pharmacological therapies - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Pharmacological therapies - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Pharmacological therapies - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Non pharmacological therapies - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Non pharmacological therapies - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Non pharmacological therapies - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Non pharmacological therapies - Year-over-year growth 2023-2028 (%)
Exhibits62: Market opportunity by Therapy ($ million)
Exhibits63: Data Table on Market opportunity by Therapy ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits105: Market opportunity By Geographical Landscape ($ million)
Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits107: Impact of drivers and challenges in 2023 and 2028
Exhibits108: Overview on criticality of inputs and factors of differentiation
Exhibits109: Overview on factors of disruption
Exhibits110: Impact of key risks on business
Exhibits111: Companies covered
Exhibits112: Matrix on companies position and classification
Exhibits113: Apotex Inc. - Overview
Exhibits114: Apotex Inc. - Product / Service
Exhibits115: Apotex Inc. - Key news
Exhibits116: Apotex Inc. - Key offerings
Exhibits117: ASSERTIO HOLDINGS INC. - Overview
Exhibits118: ASSERTIO HOLDINGS INC. - Product / Service
Exhibits119: ASSERTIO HOLDINGS INC. - Key offerings
Exhibits120: AstraZeneca Plc - Overview
Exhibits121: AstraZeneca Plc - Product / Service
Exhibits122: AstraZeneca Plc - Key news
Exhibits123: AstraZeneca Plc - Key offerings
Exhibits124: Cadila Pharmaceuticals Ltd. - Overview
Exhibits125: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits126: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits127: Cipla Inc. - Overview
Exhibits128: Cipla Inc. - Business segments
Exhibits129: Cipla Inc. - Key news
Exhibits130: Cipla Inc. - Key offerings
Exhibits131: Cipla Inc. - Segment focus
Exhibits132: Daiichi Sankyo Co. Ltd. - Overview
Exhibits133: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits134: Daiichi Sankyo Co. Ltd. - Key news
Exhibits135: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits136: Dr Reddys Laboratories Ltd. - Overview
Exhibits137: Dr Reddys Laboratories Ltd. - Business segments
Exhibits138: Dr Reddys Laboratories Ltd. - Key news
Exhibits139: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits140: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits141: Eli Lilly and Co. - Overview
Exhibits142: Eli Lilly and Co. - Product / Service
Exhibits143: Eli Lilly and Co. - Key news
Exhibits144: Eli Lilly and Co. - Key offerings
Exhibits145: Endo International Plc - Overview
Exhibits146: Endo International Plc - Business segments
Exhibits147: Endo International Plc - Key news
Exhibits148: Endo International Plc - Key offerings
Exhibits149: Endo International Plc - Segment focus
Exhibits150: Hikma Pharmaceuticals Plc - Overview
Exhibits151: Hikma Pharmaceuticals Plc - Business segments
Exhibits152: Hikma Pharmaceuticals Plc - Key news
Exhibits153: Hikma Pharmaceuticals Plc - Key offerings
Exhibits154: Hikma Pharmaceuticals Plc - Segment focus
Exhibits155: Johnson and Johnson Services Inc. - Overview
Exhibits156: Johnson and Johnson Services Inc. - Business segments
Exhibits157: Johnson and Johnson Services Inc. - Key news
Exhibits158: Johnson and Johnson Services Inc. - Key offerings
Exhibits159: Johnson and Johnson Services Inc. - Segment focus
Exhibits160: Lupin Ltd. - Overview
Exhibits161: Lupin Ltd. - Product / Service
Exhibits162: Lupin Ltd. - Key news
Exhibits163: Lupin Ltd. - Key offerings
Exhibits164: Novartis AG - Overview
Exhibits165: Novartis AG - Business segments
Exhibits166: Novartis AG - Key news
Exhibits167: Novartis AG - Key offerings
Exhibits168: Novartis AG - Segment focus
Exhibits169: Pfizer Inc. - Overview
Exhibits170: Pfizer Inc. - Product / Service
Exhibits171: Pfizer Inc. - Key news
Exhibits172: Pfizer Inc. - Key offerings
Exhibits173: Viatris Inc. - Overview
Exhibits174: Viatris Inc. - Business segments
Exhibits175: Viatris Inc. - Key news
Exhibits176: Viatris Inc. - Key offerings
Exhibits177: Viatris Inc. - Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Information sources
Exhibits183: Data validation
Exhibits184: Validation techniques employed for market sizing
Exhibits185: Data synthesis
Exhibits186: 360 degree market analysis
Exhibits187: List of abbreviations